Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Abpro Bio Co., Ltd.
  6. News
  7. Summary
    A195990   KR7195990007

ABPRO BIO CO., LTD.

(A195990)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding

10/14/2021 EST

Abpro Bio Co., Ltd. announced a private placement of 4,587,155 shares at the price of KRW 1,090 per share for gross proceeds of KRW 4,999,998,950 on October 14, 2021. The transaction will include participation from Wonjin Partners Co., Ltd. The shares will have restriction for 1 years. The face value of shares is KRW 500 per share. The method of issuance is third party allotment method. The board of directors of the company has approved the transaction. The transaction is expected to close on December 29, 2021.


ę S&P Capital IQ 2021
All news about ABPRO BIO CO., LTD.
2021Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in fund..
CI
2021Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Merit..
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from..
CI
2020Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea..
CI
2020An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpr..
CI
2020Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpr..
CI
2020Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from..
CI
2020ABPRO BIO CO., LTD.(KOSDAQ : A195990) added to S&P Global BMI Index
CI
2019An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., ..
CI
More news
Financials
Sales 2020 49 282 M 41,2 M 41,2 M
Net income 2020 -58 972 M -49,2 M -49,2 M
Net cash 2020 19 491 M 16,3 M 16,3 M
P/E ratio 2020 -6,28x
Yield 2020 -
Capitalization 197 B 164 M 164 M
EV / Sales 2019 5,28x
EV / Sales 2020 8,97x
Nbr of Employees 43
Free-Float 90,9%
Chart ABPRO BIO CO., LTD.
Duration : Period :
Abpro Bio Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABPRO BIO CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Pui Chan Ian Yan Co-Chief Executive Officer & Director
Jin-Sang Yang Co-Chief Executive Officer & Director
Jae-Hong Jeon Independent Director
Gab-Jin Kang Independent Director
Ki-Chul An Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABPRO BIO CO., LTD.-21.55%164
ESTUN AUTOMATION CO., LTD-7.63%3 266
KENNAMETAL INC.-1.98%2 944
BYSTRONIC AG-5.30%2 732
SHENZHEN YINGHE TECHNOLOGY CO., LTD-17.38%2 606
DMG MORI CO., LTD.-9.91%1 952